| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007679748 |
| P356 | DOI | 10.1038/NM.2312 |
| P932 | PMC publication ID | 3977039 |
| P698 | PubMed publication ID | 21378977 |
| P5875 | ResearchGate publication ID | 50290122 |
| P2093 | author name string | Nigel P Carter | |
| Philippos C Patsalis | |||
| Voula Velissariou | |||
| Evdokia Tsaliki | |||
| Elisavet A Papageorgiou | |||
| Alex Karagrigoriou | |||
| P2860 | cites work | Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 |
| An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs) | Q24655589 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells | Q29618090 | ||
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Hypermethylation of RASSF1A in human and rhesus placentas | Q33275493 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. | Q35216798 | ||
| Epigenomics: beyond CpG islands. | Q35778671 | ||
| Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time | Q36274725 | ||
| An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies | Q36467612 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies | Q37164146 | ||
| Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. | Q39904859 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma. | Q51959098 | ||
| Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. | Q53063252 | ||
| Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome | Q56765605 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasmaSERPINB2mRNA: a feasibility study | Q58029246 | ||
| Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21 | Q58029321 | ||
| Detection of Trisomy 21 by Quantitative Mass Spectrometric Analysis of Single-Nucleotide Polymorphisms | Q58029594 | ||
| Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma | Q77372981 | ||
| Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum | Q77543801 | ||
| Integrated screening for Down's syndrome based on tests performed during the first and second trimesters | Q78109767 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA methylation | Q874745 |
| P304 | page(s) | 510-513 | |
| P577 | publication date | 2011-03-06 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. | |
| P478 | volume | 17 |
| Q37433730 | A new method for non-invasive prenatal diagnosis of Down syndrome using MeDIP real time qPCR. |
| Q51346655 | A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCR. |
| Q48609420 | Advances in prenatal screening: the ethical dimension. |
| Q35552815 | Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis |
| Q36292917 | Array comparative genomic hybridization in prenatal diagnosis of first trimester pregnancies at high risk for chromosomal anomalies |
| Q44176018 | Author's response regarding "MeDIP-qPCR approach for non-invasive prenatal diagnosis of Down syndrome: accuracy and reproducibility". |
| Q38101277 | Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies |
| Q35738581 | Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing |
| Q47142145 | Cell-Free DNA in Oncology: Gearing up for Clinic |
| Q38547170 | Cell-free DNA as a novel marker in cancer therapy |
| Q36834331 | Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease |
| Q36790198 | Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for noninvasive prenatal diagnosis |
| Q46446186 | Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors |
| Q43819827 | Comment on "MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21". |
| Q53087139 | Counseling parents before prenatal diagnosis: do we need to say more about the sex chromosome aneuploidies? |
| Q30372298 | Current principles and practice of ethics and law in perinatal medicine. |
| Q37148677 | DNA methylation as clinically useful biomarkers-light at the end of the tunnel |
| Q37963517 | DNA methylation testing and marker validation using PCR: diagnostic applications. |
| Q50650841 | DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers for non-invasive prenatal testing. |
| Q26829214 | DNA modifications: function and applications in normal and disease States |
| Q34314087 | DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samples |
| Q61197458 | Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation |
| Q34921561 | Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? |
| Q91846514 | Development of a new methylation-based fetal fraction estimation assay using multiplex ddPCR |
| Q22241933 | Diagnostic Accuracy of Noninvasive Detection of Fetal Trisomy 21 in Maternal Blood: A Systematic Review |
| Q35020525 | Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease |
| Q35084533 | Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21 |
| Q37148718 | Epigenetic mechanisms and therapeutic perspectives for neurodevelopmental disorders |
| Q50052174 | Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma |
| Q34059853 | Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors |
| Q37948857 | Fetal nucleic acids in maternal blood: the promises |
| Q37956500 | From karyotyping to array-CGH in prenatal diagnosis |
| Q34286705 | From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges |
| Q34618332 | High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma |
| Q43494882 | How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care |
| Q53191016 | Influence of temperature during transportation on cell-free DNA analysis. |
| Q34568851 | Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS. |
| Q50435242 | Intrauterine growth retardation-associated syncytin b hypermethylation in maternal rat blood revealed by DNA methylation array analysis |
| Q27010159 | Liquid biopsies: genotyping circulating tumor DNA |
| Q31111833 | Maternal plasma sequencing: a powerful tool towards fetal whole genome recovery |
| Q41496938 | MeDIP Real-Time qPCR has the Potential for Noninvasive Prenatal Screening of Fetal Trisomy 21. |
| Q55424345 | MeDIP combined with in-solution targeted enrichment followed by NGS: Inter-individual methylation variability of fetal-specific biomarkers and their implementation in a proof of concept study for NIPT. |
| Q38126982 | Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool |
| Q27027258 | Myeloid leukemia in Down syndrome |
| Q34087801 | Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma |
| Q36079264 | Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. |
| Q51821173 | Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly. |
| Q48612533 | Non-invasive prenatal diagnosis for aneuploidy: toward an integral ethical assessment. |
| Q36424760 | Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications |
| Q26823325 | Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood |
| Q38114375 | Non-invasive prenatal testing for aneuploidy: current status and future prospects |
| Q22242878 | Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012 |
| Q40220994 | Noninvasive fetal trisomy detection by multiplexed semiconductor sequencing: a barcoding analysis strategy. |
| Q47785370 | Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithms |
| Q37998943 | Noninvasive prenatal diagnosis empowered by high-throughput sequencing |
| Q56776996 | Noninvasive prenatal tests for Down syndrome are near |
| Q36164695 | On the future of genetic risk assessment |
| Q38954748 | Prenatal and pre-implantation genetic diagnosis |
| Q36685100 | Prenatal testing for intellectual disability: misperceptions and reality with lessons from Down syndrome |
| Q50620646 | Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. |
| Q64983063 | Recent trends in prenatal genetic screening and testing. |
| Q34308038 | Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray |
| Q36954067 | Second-generation non-invasive high-throughput DNA sequencing technology in the screening of Down's syndrome in advanced maternal age women |
| Q46245098 | Steroidogenic factor-1 hypermethylation in maternal rat blood could serve as a biomarker for intrauterine growth retardation |
| Q36269719 | Targeted capture enrichment assay for non-invasive prenatal testing of large and small size sub-chromosomal deletions and duplications |
| Q56001885 | Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis |
| Q33891689 | The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis |
| Q50776877 | The dysfunctional placenta epigenome: causes and consequences. |
| Q53131950 | The introduction of arrays in prenatal diagnosis: a special challenge. |
| Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
| Q51039797 | Variability of ffDNA in maternal plasma does not prevent correct classification of trisomy 21 using MeDIP-qPCR methodology. |
| Q47949994 | Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions. |
| Q28602856 | Women's knowledge, attitudes, and beliefs about Down syndrome: a qualitative research study |
Search more.